[Clinical benefit and regimen selection for patients with newly-diagnosed multiple myeloma in the era of novel agents]

Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):297-8. doi: 10.3760/cma.j.issn.0253-2727.2013.04.010.
[Article in Chinese]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Multiple Myeloma / drug therapy*